5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase Inhibitors-Reference-Cited by-同舟云学术

5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase Inhibitors

Published:2016-04-11 Issue:6 Volume:2 Page:399-404
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Zhang Zhongsheng¹,Koh Cho Yeow¹,Ranade Ranae M.²,Shibata Sayaka¹,Gillespie J. Robert²,Hulverson Matthew A.²,Huang Wenlin¹,Nguyen Jasmine¹,Pendem Nagendar³,Gelb Michael H.³,Verlinde Christophe L. M. J.¹,Hol Wim G. J.¹,Buckner Frederick S.²,Fan Erkang¹

Affiliation:

1. Department of Biochemistry, University of Washington, 1705 N.E. Pacific Street, Seattle, Washington 98195, United States

2. Department of Medicine, Division of Allergy and Infectious Diseases, and the Center for Emerging and Re-emerging Infectious Diseases (CERID), University of Washington, 750 Republican Street, Seattle, Washington 98109, United States

3. Department of Chemistry, Bagley Hall, University of Washington, Seattle, Washington 98195, United States

Funder

Basic Energy Sciences

National Institute of Allergy and Infectious Diseases

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

http://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.6b00036

Reference26 articles.